AngioDynamics director Dennis Meteny to retire Jan 31, 2024; board reduced to 8

ANGIODYNAMICS INC

Dennis Meteny to retire from Board and as chair of Audit Committee, effective Jan 31, 2024.
Meteny served on Board since 2004; retirement not due to any disagreement with Company.
Board will not appoint replacement; size reduced from 9 to 8 directors.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dennis Meteny

member of the Board of Directors

ANGO · ANGIODYNAMICS INC

Effective: 2024-01-31
Filed: January 22, 2024, 6:59 PM ET

On January 16, 2024, Dennis Meteny announced his intention to retire and resign from his position as a member of the Board of Directors (the “Board”) of AngioDynamics, Inc. (“AngioDynamics” or the “Company”) and as a member of the Compensation Committee and chair of the Audit Committee, effective January 31, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Dennis Meteny resigned as member of the Board of Directors at ANGIODYNAMICS INC.

Action: resigned
Role: member of the Board of Directors

Exact text from the filing

On January 16, 2024, Dennis Meteny announced his intention to retire and resign from his position as a member of the Board of Directors (the “Board”) of AngioDynamics, Inc. (“AngioDynamics” or the “Company”) and as a member of the Compensation Committee and chair of the Audit Committee, effective January 31, 2024.

View on SEC.gov

ANGIODYNAMICS INC filing history →

Source: SEC EDGAR

accession 0001140361-24-002997

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.